Table 1.
Clinical parameters | No. of patients | KLK6a Low/high | KLK8a Low/high | KLK6+KLK8b Low/high |
---|---|---|---|---|
| ||||
Total no. of patients | 100 | 49/50 | 50/50 | 34/65 |
| ||||
Age | P = 0.919 | P = 0.841 | P = 0.942 | |
≤ 60 years | 49 | 24/25 | 25/24 | 17/32 |
> 60 years | 51 | 25/25 | 25/26 | 17/33 |
| ||||
Residual tumor mass | P = 0.230 | P = 0.359 | P = 0.062 | |
0 mm | 45 | 25/20 | 25/20 | 20/25 |
> 0 mm | 54 | 23/30 | 25/29 | 14/39 |
| ||||
Ascitic fluid volume | P = 0.875 | P = 0.551 | P = 0.264 | |
≤ 500 ml | 46 | 25/21 | 26/20 | 20/26 |
> 500 ml | 38 | 20/18 | 19/19 | 12/26 |
Chi-square test (cutoff point = median)
High KLK6+KLK8: KLK6 and/or KLK8 above median; low KLK6+KLK8: KLK6 and KLK8 both below median